Latest news
Grace Therapeutics (GRCE): Opaleye reports 2.75M-share, 13.07% ownership stake - Stock TitanStock Titan · Fri, 07 Aug 2026 20:06:08 GMTGRCE Stock On Track For Worst Week In 5.5 Years — What’s Driving The Selloff? - StocktwitsStocktwits · Fri, 07 Aug 2026 13:48:41 GMTGrace Therapeutics, Inc. Revenue Breakdown – NASDAQ:GRCE - TradingViewTradingView · Fri, 07 Aug 2026 12:57:52 GMTGRCE Stock Plunges 45% After FDA Rejects Brain Injury Drug — Company Says Concerns Are Fixable - StocktwitsStocktwits · Fri, 07 Aug 2026 08:05:22 GMTGrace Therapeutics Raises $10 Million in Private Placement, Grants Registration Rights - TradingViewTradingView · Thu, 06 Aug 2026 20:13:22 GMTGRCE 8-K & SEC Filings - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 07:00:00 GMTGrace Therapeutics (GRCE) Advances Dual-Source Manufacturing Ami - GuruFocusGuruFocus · Wed, 05 Aug 2026 11:44:11 GMTGRCE Q1'26 Earnings: EPS estimate is (0.13) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:59 GMT